Form 483

Acella Pharmaceuticals, LLC Form 483, 2015-10-28

FDA issued a Form 483 to Acella Pharmaceuticals, LLC on 2015-10-28 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Acella Pharmaceuticals, LLC · Alpharetta, United States · Issued October 28, 2015

Overview

  • 6 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Oct 2015
21 CFR 111.455(a)

Hold - temperature, humidity, light

Cited by Joseph F Owens, Larry K Hampton, Tamara J Henderson

28 Oct 2015
21 CFR 111.455(a)

Hold - temperature, humidity, light

Cited by Joseph F Owens, Larry K Hampton, Tamara J Henderson

28 Oct 2015
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Joseph F Owens, Larry K Hampton, Tamara J Henderson

28 Oct 2015
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Joseph F Owens, Larry K Hampton, Tamara J Henderson

28 Oct 2015
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Joseph F Owens, Larry K Hampton, Tamara J Henderson

Inspected site

APAcella Pharmaceuticals, LLCAlpharetta, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.455(a)Cited across public-safe Form 483 observations2x
21 CFR 211.142(b)Cited across public-safe Form 483 observations2x
21 CFR 211.22(d)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere